Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Asacol Acute Diverticulitis(DIVA)Study

ClinicalTrials.gov ID: NCT00554099

Public ClinicalTrials.gov record NCT00554099. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 5:27 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of a 12 Week Treatment of Acute Diverticulitis With Asacol® 2.4 g/Day (400 mg Mesalamine Tablet), Followed by a 9 Month Treatment-free Observation Period

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine whether Asacol® 2.4 g/day (400 mg Mesalamine) is safe and effective in the treatment of diverticulitis.

Study identification

NCT ID
NCT00554099
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Warner Chilcott
Industry
Enrollment
117 participants

Conditions and interventions

Eligibility (public fields only)

Age range
35 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2007 (Type not available)
Primary completion
Mar 2010 (Actual)
Completion
Mar 2010 (Actual)
Last update posted
Apr 22, 2013

2007 – 2010

United States locations

U.S. sites
36
U.S. states
17
U.S. cities
36
Facility City State ZIP Site status
Research Site Tucson Arizona — —
Research Facility Los Angeles California — —
Research Site Merced California — —
Research Site Oakland California — —
Research Facility Orange California — —
Research Site Palm Springs California — —
Research Site Pasadena California — —
Research Site Lafayette Colorado — —
Research Site Littleton Colorado — —
Research Site Boynton Beach Florida — —
Research Site Jacksonsville Florida — —
Research Site Jacksonville Florida — —
Research Site Winter Park Florida — —
Research Facility Zephyrhills Florida — —
Research Site Pratt Kansas — —
Research Site Monroe Louisiana — —
Research Site Shreveport Louisiana — —
Research Site Chesterfield Michigan — —
Research Site Tupelo Mississippi — —
Research Site Mexico Missouri — —
Research Facility Cedar Knolls New Jersey — —
Research Site Great Neck New York — —
Research Site Lake Success New York — —
Research Site Setauket New York — —
Research Site Asheville North Carolina — —
Research Site Greenville North Carolina — —
Research Facility Harrisburg North Carolina — —
Research Site Morganton North Carolina — —
Research Site Wilmington North Carolina — —
Research Site Winston-Salem North Carolina — —
Research Site Cincinnati Ohio — —
Research Site Cranston Rhode Island — —
Research Site Longview Texas — —
Research Site Odessa Texas — —
Research Site Chesapeake Virginia — —
Research Facility Monroe Wisconsin — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00554099, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 22, 2013 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00554099 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →